ES476106A1 - Procedimiento para la preparacion de 4-espectinomicilamina. - Google Patents

Procedimiento para la preparacion de 4-espectinomicilamina.

Info

Publication number
ES476106A1
ES476106A1 ES476106A ES476106A ES476106A1 ES 476106 A1 ES476106 A1 ES 476106A1 ES 476106 A ES476106 A ES 476106A ES 476106 A ES476106 A ES 476106A ES 476106 A1 ES476106 A1 ES 476106A1
Authority
ES
Spain
Prior art keywords
spectinomycylamin
substances
preparation
acceptable salts
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476106A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES476106A1 publication Critical patent/ES476106A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Procedimiento para la preparación de 4-espectinomicilamina de la fórmula y de sus sales por adición de ácido con ácidos inorgánicos u orgánicos, que se caracteriza porque a) se hodrogena un derivado espectinomicínico de la fórmula general donde X significa un átomo de hidrógeno, un grupo orgánico, conocido a partir de la química de los péptidos, fácilmente separable mediante reducción, tal como el grupo benciloxicarbonilo, el grupò 4-bromo- ó 4-nitro-ó 4-cloro- benciloxicarbonilo, el grupo 4-metoxi ó 3,4,- dimetoxi- ¿3,4-metilen-dihidroxi- ó 3,4,5- trimetoxi- ó deciloxi ó 4- acetoxi- ó etoxi-carboniloxibenciloxicarbonilo *** ver imagen 01 *** ver imagen 02 *** ver imagen 03
ES476106A 1977-12-21 1978-12-19 Procedimiento para la preparacion de 4-espectinomicilamina. Expired ES476106A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772756914 DE2756914A1 (de) 1977-12-21 1977-12-21 4-spectinomycylamin und seine physiologisch vertraegliche salze, verfahren zur herstellung und diese stoffe enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES476106A1 true ES476106A1 (es) 1979-04-16

Family

ID=6026673

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476106A Expired ES476106A1 (es) 1977-12-21 1978-12-19 Procedimiento para la preparacion de 4-espectinomicilamina.

Country Status (18)

Country Link
US (1) US4173647A (es)
EP (1) EP0002680B1 (es)
JP (1) JPS5488299A (es)
AT (1) AT362064B (es)
AU (1) AU523036B2 (es)
CA (1) CA1112649A (es)
DE (2) DE2756914A1 (es)
DK (1) DK572578A (es)
ES (1) ES476106A1 (es)
FI (1) FI783900A (es)
GR (1) GR65649B (es)
HU (1) HU178126B (es)
IL (1) IL56248A (es)
NO (1) NO784299L (es)
NZ (1) NZ189246A (es)
PH (1) PH13871A (es)
PT (1) PT68939A (es)
ZA (1) ZA787236B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282152A (en) * 1979-08-23 1981-08-04 The Upjohn Company Intermediates for preparing spectinomycin and analogs thereof
US4337347A (en) * 1979-08-23 1982-06-29 The Upjohn Company Process for preparing analogs of spectinomycin
US4345086A (en) * 1979-08-23 1982-08-17 The Upjohn Company Intermediate compounds in the preparation of spectinomycin
US4344882A (en) * 1979-08-23 1982-08-17 The Upjohn Company Intermediate compounds in the preparation of spectinomycin
US4465848A (en) * 1981-10-23 1984-08-14 The Upjohn Company Spectinomycin compounds
US4532336A (en) * 1982-03-19 1985-07-30 The Upjohn Company 6'-Alkylspectinomycins
JPS5945890A (ja) * 1982-09-09 1984-03-14 Toyo Jozo Co Ltd 新規抗生物質アクミマイシンおよびその製造法
US4523022A (en) * 1983-07-07 1985-06-11 The Upjohn Company Analogs of the antibiotic spectinomycin
US4603212A (en) * 1983-10-18 1986-07-29 The Upjohn Company Analogs of the antibiotic spectinomycin
US4578485A (en) * 1984-02-08 1986-03-25 The Upjohn Company Synthesis of spectinomycin analogs by an improved Grignard process
DE3500005A1 (de) * 1985-01-02 1986-07-10 ESB Elektrostatische Sprüh- und Beschichtungsanlagen G.F. Vöhringer GmbH, 7758 Meersburg Beschichtungskabine zum ueberziehen der oberflaeche von werkstuecken mit beschichtungspulver
WO1986005686A2 (en) * 1985-03-29 1986-10-09 The Upjohn Company Treating chlamydia infections using spectinomycin analogs
AU2010275375B2 (en) * 2009-07-24 2016-01-21 University Of Tennessee Research Foundation Spectinamides as anti-tuberculosis agents
JP6545177B2 (ja) * 2013-09-29 2019-07-17 セント ジュード チルドレンズ リサーチ ホスピタル インコーポレイテッド 抗菌薬としてのアリール置換アミノメチルスペクチノマイシン類似体
JP6923290B2 (ja) * 2015-11-18 2021-08-18 グローリー株式会社 貨幣処理装置および貨幣処理方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165533A (en) * 1962-01-22 1965-01-12 Upjohn Co Dihydroactinospectacin, amides and esters thereof
US3147277A (en) * 1962-02-09 1964-09-01 Upjohn Co Nu, nu'-bis (alpha-sulfoalkyl) actinospectacins and process for their production

Also Published As

Publication number Publication date
FI783900A (fi) 1979-06-22
HU178126B (en) 1982-03-28
DK572578A (da) 1979-06-22
DE2756914A1 (de) 1979-07-05
IL56248A0 (en) 1979-03-12
CA1112649A (en) 1981-11-17
AT362064B (de) 1981-04-27
AU523036B2 (en) 1982-07-08
PH13871A (en) 1980-10-24
EP0002680A2 (de) 1979-07-11
EP0002680A3 (en) 1979-07-25
NO784299L (no) 1979-06-22
ZA787236B (en) 1980-08-27
JPS5488299A (en) 1979-07-13
US4173647A (en) 1979-11-06
AU4275478A (en) 1979-06-28
EP0002680B1 (de) 1981-02-11
PT68939A (de) 1979-01-01
DE2860490D1 (en) 1981-03-26
GR65649B (en) 1980-10-15
IL56248A (en) 1982-08-31
NZ189246A (en) 1981-03-16
ATA863178A (de) 1980-09-15

Similar Documents

Publication Publication Date Title
DE2861729D1 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
ES8202799A1 (es) Procedimiento para la preparacion de sulfonilureas
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
ES2017839A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales>
ES8101068A1 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
DE2862419D1 (en) Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
ES8107216A1 (es) Procedimiento para la preparacion de sulfonilureas
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES480111A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
ES473038A1 (es) Procedimiento para la obtencion de 2-guanidinometil-indoli- nas
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
ES8506710A1 (es) Procedimiento para la obtencion de teofilin-7-acetato de ambroxol
IE43848L (en) Pharmaceutical compositions